112 related articles for article (PubMed ID: 15668503)
1. PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection.
Castle PE; Schiffman M; Herrero R; Hildesheim A; Rodriguez AC; Bratti MC; Wacholder S; Kendal H; Breheny AM; Prior A; Pfeiffer R; Burk RD
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):256-60. PubMed ID: 15668503
[TBL] [Abstract][Full Text] [Related]
2. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
4. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort.
LaMere BJ; Kornegay J; Fetterman B; Sadorra M; Shieh J; Castle PE;
J Virol Methods; 2007 Dec; 146(1-2):80-5. PubMed ID: 17673302
[TBL] [Abstract][Full Text] [Related]
6. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
[TBL] [Abstract][Full Text] [Related]
7. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study.
Castle PE; Gravitt PE; Solomon D; Wheeler CM; Schiffman M
J Clin Microbiol; 2008 Jan; 46(1):109-17. PubMed ID: 17989194
[TBL] [Abstract][Full Text] [Related]
8. Clinical performance of the CLART human papillomavirus 2 assay compared with the hybrid capture 2 test.
Pista A; Verdasca N; Oliveira A
J Med Virol; 2011 Feb; 83(2):272-6. PubMed ID: 21181922
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
[TBL] [Abstract][Full Text] [Related]
10. Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.
Onuki M; Matsumoto K; Sakurai M; Ochi H; Minaguchi T; Satoh T; Yoshikawa H
J Gynecol Oncol; 2016 Jan; 27(1):e3. PubMed ID: 26463429
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
Castle PE; Solomon D; Schiffman M; Wheeler CM
J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
[TBL] [Abstract][Full Text] [Related]
12. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens.
Cope JU; Hildesheim A; Schiffman MH; Manos MM; Lörincz AT; Burk RD; Glass AG; Greer C; Buckland J; Helgesen K; Scott DR; Sherman ME; Kurman RJ; Liaw KL
J Clin Microbiol; 1997 Sep; 35(9):2262-5. PubMed ID: 9276398
[TBL] [Abstract][Full Text] [Related]
14. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.
Sellors JW; Lorincz AT; Mahony JB; Mielzynska I; Lytwyn A; Roth P; Howard M; Chong S; Daya D; Chapman W; Chernesky M
CMAJ; 2000 Sep; 163(5):513-8. PubMed ID: 11006761
[TBL] [Abstract][Full Text] [Related]
15. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica.
Schiffman M; Herrero R; Hildesheim A; Sherman ME; Bratti M; Wacholder S; Alfaro M; Hutchinson M; Morales J; Greenberg MD; Lorincz AT
JAMA; 2000 Jan; 283(1):87-93. PubMed ID: 10632285
[TBL] [Abstract][Full Text] [Related]
16. A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
Schiffman M; Glass AG; Wentzensen N; Rush BB; Castle PE; Scott DR; Buckland J; Sherman ME; Rydzak G; Kirk P; Lorincz AT; Wacholder S; Burk RD
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1398-409. PubMed ID: 21602310
[TBL] [Abstract][Full Text] [Related]
17. A novel filtration-based processing method of liquid cytology specimens for human papillomavirus DNA testing by hybrid capture II.
Castle PE; Garcia-Meijide M; Holladay EB; Chuke R; Payne J; Long A; Siefers H; Demuth F; Lorincz AT
Am J Clin Pathol; 2005 Feb; 123(2):250-5. PubMed ID: 15842050
[TBL] [Abstract][Full Text] [Related]
18. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
19. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Khan MJ; Castle PE; Lorincz AT; Wacholder S; Sherman M; Scott DR; Rush BB; Glass AG; Schiffman M
J Natl Cancer Inst; 2005 Jul; 97(14):1072-9. PubMed ID: 16030305
[TBL] [Abstract][Full Text] [Related]
20. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
Gravitt PE; Kovacic MB; Herrero R; Schiffman M; Bratti C; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Rodriguez AC; Burk RD
Int J Cancer; 2007 Dec; 121(12):2787-93. PubMed ID: 17722112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
